Učitavanje...
Omalizumab in children with severe allergic disease: a case series
BACKGROUND: Currently, severe allergic asthma and food allergy in children represent an important public health problem with medical, psychosocial and economic impacts. Omalizumab is a humanized monoclonal anti-IgE antibody, approved for refractory allergic asthma and chronic urticaria. It has been...
Spremljeno u:
| Izdano u: | Ital J Pediatr |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6332555/ https://ncbi.nlm.nih.gov/pubmed/30642367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-019-0602-5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|